Astera Labs (ALAB) is trading at $228.16, up 2.95% on the latest session, after a record third-quarter revenue print of $584.9 million on November 3, 2026. The stock is trying to hold above its sho...
Astera Labs reported third-quarter 2026 revenue of $584.9 million on November 3, 2026, up 49% sequentially and 154% year over year, with Scorpio fabric switches becoming the company’s largest product family by revenue as the Scorpio X-Series 320-lane switch moved into high-volume production. That matters because it confirms the AI networking story is still translating into real top-line scale, not just expectations.
The market is still digesting that update. BMO initiated coverage on November 5 with an outperform rating and a $375 target, saying Astera Labs stands to benefit from the AI build-out and describing the company as a critical AI networking leader. Other recent broker notes cited by TradingView show a wide target range, including RBC at $400, Evercore ISI at $311, Susquehanna at $258, Needham at $300 and TD Cowen at $300.
ALAB shares last traded at $228.16, above the 7-day SMA of $217.66, the 20-day SMA of $218.64 and the pivot point at $222.14. That puts the stock in a short-term recovery phase rather than a clean trend reversal.
The catch is the longer-term structure is still damaged. The 50-day SMA sits much higher at $273.28, and the 26-day EMA at $233.90 is still overhead. In other words, ALAB has reclaimed nearby support, but it has not yet repaired the broader downtrend.
Source link







